Related Experiment Videos
[Refining the indications for atropine-coma therapy]
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1977
Summary
Atropine-comatose therapy showed improvement in 11 of 18 schizophrenia patients with obsessive disorders. The study identified distinct psychopathological traits correlating with treatment response in obsessive-compulsive symptoms.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Context:
- Schizophrenia and obsessive disorders present complex treatment challenges.
- Understanding the psychopathology of obsessive symptoms is crucial for effective intervention.
- Atropine-comatose therapy has been explored as a treatment modality.
Purpose:
- To evaluate the efficacy of atropine-comatose therapy in patients with schizophrenia and obsessive disorders.
- To analyze the psychopathological characteristics of obsessive disorders in this patient group.
- To identify factors associated with treatment response or lack thereof.
Summary:
- Atropine-comatose therapy was administered to 18 patients diagnosed with schizophrenia and obsessive disorders.
- Eleven patients (61%) exhibited improvement in their condition following the therapy.
- Psychopathological analysis revealed that patients who improved had complex, abstract, and expanding obsessions, while non-responders presented with monotonous, everyday obsessions akin to psychasthenic doubtfulness.
Impact:
- This study suggests atropine-comatose therapy may be beneficial for a subset of schizophrenia patients with specific obsessive disorder profiles.
- Identifying distinct psychopathological traits can aid in predicting treatment outcomes for obsessive-compulsive symptoms.
- Further research is warranted to elucidate the mechanisms and optimize the application of atropine-comatose therapy.